Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

COUSIN (COdon Usage Similarity INdex): A Normalized Measure of Codon Usage Preferences.

Bourret J, Alizon S, Bravo IG.

Genome Biol Evol. 2019 Dec 1;11(12):3523-3528. doi: 10.1093/gbe/evz262.

2.

Natural history, dynamics, and ecology of human papillomaviruses in genital infections of young women: protocol of the PAPCLEAR cohort study.

Murall CL, Rahmoun M, Selinger C, Baldellou M, Bernat C, Bonneau M, Boué V, Buisson M, Christophe G, D'Auria G, Taroni F, Foulongne V, Froissart R, Graf C, Grasset S, Groc S, Hirtz C, Jaussent A, Lajoie J, Lorcy F, Picot E, Picot MC, Ravel J, Reynes J, Rousset T, Seddiki A, Teirlinck M, Tribout V, Tuaillon É, Waterboer T, Jacobs N, Bravo IG, Segondy M, Boulle N, Alizon S.

BMJ Open. 2019 Jun 11;9(6):e025129. doi: 10.1136/bmjopen-2018-025129.

3.

Genome Plasticity in Papillomaviruses and De Novo Emergence of E5 Oncogenes.

Willemsen A, Félez-Sánchez M, Bravo IG.

Genome Biol Evol. 2019 Jun 1;11(6):1602-1617. doi: 10.1093/gbe/evz095.

4.

Origin and evolution of papillomavirus (onco)genes and genomes.

Willemsen A, Bravo IG.

Philos Trans R Soc Lond B Biol Sci. 2019 May 27;374(1773):20180303. doi: 10.1098/rstb.2018.0303.

5.

Towards a multi-level and a multi-disciplinary approach to DNA oncovirus virulence.

Alizon S, Bravo IG, Farrell PJ, Roberts S.

Philos Trans R Soc Lond B Biol Sci. 2019 May 27;374(1773):20190041. doi: 10.1098/rstb.2019.0041.

6.

Evolutionary Changes after Translational Challenges Imposed by Horizontal Gene Transfer.

Bedhomme S, Amorós-Moya D, Valero LM, Bonifaci N, Pujana MÀ, Bravo IG.

Genome Biol Evol. 2019 Mar 1;11(3):814-831. doi: 10.1093/gbe/evz031.

7.

Human papillomavirus DNA detected in fingertip, oral and bathroom samples from unvaccinated adolescent girls in Tanzania.

Houlihan CF, Baisley K, Bravo IG, Pavón MA, Changalucha J, Kapiga S, De Sanjosé S, Ross DA, Hayes RJ, Watson-Jones D.

Sex Transm Infect. 2019 Aug;95(5):374-379. doi: 10.1136/sextrans-2018-053756. Epub 2019 Jan 13.

8.

The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients.

Taberna M, Torres M, Alejo M, Mena M, Tous S, Marquez S, Pavón MA, León X, García J, Guix M, Hijano R, Bonfill T, Aguilà A, Lozano A, Mesía R, Alemany L, Bravo IG.

Front Oncol. 2018 Dec 11;8:589. doi: 10.3389/fonc.2018.00589. eCollection 2018.

9.

Distinct geographic clustering of oncogenic human papillomaviruses multiple infections in cervical cancers: Results from a worldwide cross-sectional study.

Pimenoff VN, Tous S, Benavente Y, Alemany L, Quint W, Bosch FX, Bravo IG, de Sanjosé S.

Int J Cancer. 2019 May 15;144(10):2478-2488. doi: 10.1002/ijc.31964. Epub 2018 Dec 11.

PMID:
30387873
10.

Two Novel, Distantly Related Papillomaviruses Isolated from Healthy Skin of the Timor Deer (Rusa timorensis).

Mengual-Chuliá B, Wibbelt G, Gottschling M, Bravo IG.

Genome Announc. 2018 Jun 14;6(24). pii: e00505-18. doi: 10.1128/genomeA.00505-18.

11.

Genome Sequences of Two Novel Papillomaviruses Isolated from Healthy Skin of Pudu puda and Cervus elaphus Deer.

Mengual-Chuliá B, Wittstatt U, Olias P, Bravo IG.

Genome Announc. 2018 May 3;6(18). pii: e00298-18. doi: 10.1128/genomeA.00298-18.

12.

Double positivity for HPV-DNA/p16ink4a is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients.

Mena M, Taberna M, Tous S, Marquez S, Clavero O, Quiros B, Lloveras B, Alejo M, Leon X, Quer M, Bagué S, Mesia R, Nogués J, Gomà M, Aguila A, Bonfill T, Blazquez C, Guix M, Hijano R, Torres M, Holzinger D, Pawlita M, Pavon MA, Bravo IG, de Sanjosé S, Bosch FX, Alemany L.

Oral Oncol. 2018 Mar;78:137-144. doi: 10.1016/j.oraloncology.2018.01.010. Epub 2018 Feb 20.

PMID:
29496041
13.

Stably expressed APOBEC3H forms a barrier for cross-species transmission of simian immunodeficiency virus of chimpanzee to humans.

Zhang Z, Gu Q, de Manuel Montero M, Bravo IG, Marques-Bonet T, Häussinger D, Münk C.

PLoS Pathog. 2017 Dec 21;13(12):e1006746. doi: 10.1371/journal.ppat.1006746. eCollection 2017 Dec.

14.

Why Human Papillomavirus Acute Infections Matter.

Alizon S, Murall CL, Bravo IG.

Viruses. 2017 Oct 10;9(10). pii: E293. doi: 10.3390/v9100293. Review.

15.

Evolutionary analysis of Old World arenaviruses reveals a major adaptive contribution of the viral polymerase.

Pontremoli C, Forni D, Cagliani R, Pozzoli U, Riva S, Bravo IG, Clerici M, Sironi M.

Mol Ecol. 2017 Oct;26(19):5173-5188. doi: 10.1111/mec.14282. Epub 2017 Sep 5.

PMID:
28779541
16.

Squamous intraepithelial lesions of the anal squamocolumnar junction: Histopathological classification and HPV genotyping.

Clavero O, McCloskey J, Molina VM, Quirós B, Bravo IG, de Sanjosé S, Bosch FX, Pimenoff VN.

Papillomavirus Res. 2017 Jun;3:11-17. doi: 10.1016/j.pvr.2016.12.001. Epub 2016 Dec 9.

17.

Plasmid and clonal interference during post horizontal gene transfer evolution.

Bedhomme S, Perez Pantoja D, Bravo IG.

Mol Ecol. 2017 Apr;26(7):1832-1847. doi: 10.1111/mec.14056. Epub 2017 Mar 13.

18.

Differential HPV16 variant distribution in squamous cell carcinoma, adenocarcinoma and adenosquamous cell carcinoma.

Nicolás-Párraga S, Alemany L, de Sanjosé S, Bosch FX, Bravo IG; RIS HPV TT and HPV VVAP study groups.

Int J Cancer. 2017 May 1;140(9):2092-2100. doi: 10.1002/ijc.30636. Epub 2017 Mar 1.

19.

Transmission between Archaic and Modern Human Ancestors during the Evolution of the Oncogenic Human Papillomavirus 16.

Pimenoff VN, de Oliveira CM, Bravo IG.

Mol Biol Evol. 2017 Jan;34(1):4-19. doi: 10.1093/molbev/msw214. Epub 2016 Oct 7.

20.

HPV16 variants distribution in invasive cancers of the cervix, vulva, vagina, penis, and anus.

Nicolás-Párraga S, Gandini C, Pimenoff VN, Alemany L, de Sanjosé S, Xavier Bosch F, Bravo IG; RIS HPV TT and HPV VVAP study groups.

Cancer Med. 2016 Oct;5(10):2909-2919. doi: 10.1002/cam4.870. Epub 2016 Sep 21.

21.

Searching beyond the usual papillomavirus suspects in squamous carcinomas of the vulva, penis and head and neck.

Félez-Sánchez M, Vergara M, de Sanjosé S, Castellsagué X, Alemany L, Bravo IG; VVAPO/RIS HPV TT study groups.

Infect Genet Evol. 2016 Nov;45:198-204. doi: 10.1016/j.meegid.2016.09.003. Epub 2016 Sep 4.

PMID:
27600594
22.

Determinants of FIV and HIV Vif sensitivity of feline APOBEC3 restriction factors.

Zhang Z, Gu Q, Jaguva Vasudevan AA, Hain A, Kloke BP, Hasheminasab S, Mulnaes D, Sato K, Cichutek K, Häussinger D, Bravo IG, Smits SH, Gohlke H, Münk C.

Retrovirology. 2016 Jul 1;13(1):46. doi: 10.1186/s12977-016-0274-9.

23.

Rapid acquisition of HPV around the time of sexual debut in adolescent girls in Tanzania.

Houlihan CF, Baisley K, Bravo IG, Kapiga S, de Sanjosé S, Changalucha J, Ross DA, Hayes RJ, Watson-Jones D.

Int J Epidemiol. 2016 Jun;45(3):762-73. doi: 10.1093/ije/dyv367. Epub 2016 Mar 4.

24.

Assessing parallel gene histories in viral genomes.

Mengual-Chuliá B, Bedhomme S, Lafforgue G, Elena SF, Bravo IG.

BMC Evol Biol. 2016 Feb 5;16:32. doi: 10.1186/s12862-016-0605-4.

25.

HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients.

Castellsagué X, Alemany L, Quer M, Halec G, Quirós B, Tous S, Clavero O, Alòs L, Biegner T, Szafarowski T, Alejo M, Holzinger D, Cadena E, Claros E, Hall G, Laco J, Poljak M, Benevolo M, Kasamatsu E, Mehanna H, Ndiaye C, Guimerà N, Lloveras B, León X, Ruiz-Cabezas JC, Alvarado-Cabrero I, Kang CS, Oh JK, Garcia-Rojo M, Iljazovic E, Ajayi OF, Duarte F, Nessa A, Tinoco L, Duran-Padilla MA, Pirog EC, Viarheichyk H, Morales H, Costes V, Félix A, Germar MJ, Mena M, Ruacan A, Jain A, Mehrotra R, Goodman MT, Lombardi LE, Ferrera A, Malami S, Albanesi EI, Dabed P, Molina C, López-Revilla R, Mandys V, González ME, Velasco J, Bravo IG, Quint W, Pawlita M, Muñoz N, de Sanjosé S, Xavier Bosch F; ICO International HPV in Head and Neck Cancer Study Group.

J Natl Cancer Inst. 2016 Jan 28;108(6):djv403. doi: 10.1093/jnci/djv403. Print 2016 Jun.

PMID:
26823521
26.

The Incidence of Human Papillomavirus in Tanzanian Adolescent Girls Before Reported Sexual Debut.

Houlihan CF, Baisley K, Bravo IG, Kapiga S, de Sanjosé S, Changalucha J, Ross DA, Hayes RJ, Watson-Jones D.

J Adolesc Health. 2016 Mar;58(3):295-301. doi: 10.1016/j.jadohealth.2015.10.248. Epub 2015 Dec 22.

27.

High-level of viral genomic diversity in cervical cancers: A Brazilian study on human papillomavirus type 16.

de Oliveira CM, Bravo IG, Santiago e Souza NC, Genta ML, Fregnani JH, Tacla M, Carvalho JP, Longatto-Filho A, Levi JE.

Infect Genet Evol. 2015 Aug;34:44-51. doi: 10.1016/j.meegid.2015.07.002. Epub 2015 Jul 6.

PMID:
26160543
28.

Cancer, Warts, or Asymptomatic Infections: Clinical Presentation Matches Codon Usage Preferences in Human Papillomaviruses.

Félez-Sánchez M, Trösemeier JH, Bedhomme S, González-Bravo MI, Kamp C, Bravo IG.

Genome Biol Evol. 2015 Jul 1;7(8):2117-35. doi: 10.1093/gbe/evv129.

29.

The First Papillomavirus Isolated from Vulpes vulpes (VvulPV1) Is Basal to the Gammapapillomavirus Genus.

Mengual-Chuliá B, Wittstatt U, Bravo IG.

Genome Announc. 2015 Mar 19;3(2). pii: e00111-15. doi: 10.1128/genomeA.00111-15.

30.

Disagreement in high-grade/low-grade intraepithelial neoplasia and high-risk/low-risk HPV infection: clinical implications for anal cancer precursor lesions in HIV-positive and HIV-negative MSM.

Pimenoff VN, Félez-Sánchez M, Tous S, Clavero O, Godínez JM, Klaustermeier J, Saunier M, Molijn A, Alemany L, Quint W, Bosch FX, de Sanjosé S, McCloskey J, Bravo IG.

Clin Microbiol Infect. 2015 Jun;21(6):605.e11-9. doi: 10.1016/j.cmi.2015.02.009. Epub 2015 Feb 17.

31.

Papillomaviruses: Viral evolution, cancer and evolutionary medicine.

Bravo IG, Félez-Sánchez M.

Evol Med Public Health. 2015 Jan 28;2015(1):32-51. doi: 10.1093/emph/eov003. Review.

32.

Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.

Alemany L, Saunier M, Tinoco L, Quirós B, Alvarado-Cabrero I, Alejo M, Joura EA, Maldonado P, Klaustermeier J, Salmerón J, Bergeron C, Petry KU, Guimerà N, Clavero O, Murillo R, Clavel C, Wain V, Geraets DT, Jach R, Cross P, Carrilho C, Molina C, Shin HR, Mandys V, Nowakowski AM, Vidal A, Lombardi L, Kitchener H, Sica AR, Magaña-León C, Pawlita M, Quint W, Bravo IG, Muñoz N, de Sanjosé S, Bosch FX; HPV VVAP study group.

Eur J Cancer. 2014 Nov;50(16):2846-54. doi: 10.1016/j.ejca.2014.07.018. Epub 2014 Aug 21.

PMID:
25155250
33.

Ribosomal mutations affecting the translation of genes that use non-optimal codons.

Pelchovich G, Nadejda S, Dana A, Tuller T, Bravo IG, Gophna U.

FEBS J. 2014 Aug;281(16):3701-18. doi: 10.1111/febs.12892. Epub 2014 Aug 8.

34.

A novel papillomavirus isolated from a nasal neoplasia in an Italian free-ranging chamois (Rupicapra r. rupicapra).

Mengual-Chuliá B, Domenis L, Robetto S, Bravo IG.

Vet Microbiol. 2014 Aug 6;172(1-2):108-19. doi: 10.1016/j.vetmic.2014.05.006. Epub 2014 May 14.

PMID:
24910075
35.

Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide.

Alemany L, Saunier M, Alvarado-Cabrero I, Quirós B, Salmeron J, Shin HR, Pirog EC, Guimerà N, Hernandez-Suarez G, Felix A, Clavero O, Lloveras B, Kasamatsu E, Goodman MT, Hernandez BY, Laco J, Tinoco L, Geraets DT, Lynch CF, Mandys V, Poljak M, Jach R, Verge J, Clavel C, Ndiaye C, Klaustermeier J, Cubilla A, Castellsagué X, Bravo IG, Pawlita M, Quint WG, Muñoz N, Bosch FX, de Sanjosé S; HPV VVAP Study Group.

Int J Cancer. 2015 Jan 1;136(1):98-107. doi: 10.1002/ijc.28963. Epub 2014 May 30.

36.

Interlaboratory reproducibility and proficiency testing within the human papillomavirus cervical cancer screening program in Catalonia, Spain.

Ibáñez R, Félez-Sánchez M, Godínez JM, Guardià C, Caballero E, Juve R, Combalia N, Bellosillo B, Cuevas D, Moreno-Crespi J, Pons L, Autonell J, Gutierrez C, Ordi J, de Sanjosé S, Bravo IG.

J Clin Microbiol. 2014 May;52(5):1511-8. doi: 10.1128/JCM.00100-14. Epub 2014 Feb 26.

37.

Novel papillomaviruses in free-ranging Iberian bats: no virus-host co-evolution, no strict host specificity, and hints for recombination.

García-Pérez R, Ibáñez C, Godínez JM, Aréchiga N, Garin I, Pérez-Suárez G, de Paz O, Juste J, Echevarría JE, Bravo IG.

Genome Biol Evol. 2014 Jan;6(1):94-104. doi: 10.1093/gbe/evt211.

38.

Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007.

Alemany L, de Sanjosé S, Tous S, Quint W, Vallejos C, Shin HR, Bravo LE, Alonso P, Lima MA, Guimerà N, Klaustermeier J, Llombart-Bosch A, Kasamatsu E, Tatti SA, Felix A, Molina C, Velasco J, Lloveras B, Clavero O, Lerma E, Laco J, Bravo IG, Guarch R, Pelayo A, Ordi J, Andújar M, Sanchez GI, Castellsagué X, Muñoz N, Bosch FX; RIS HPV TT Study Group.

Int J Cancer. 2014 Jul 1;135(1):88-95. doi: 10.1002/ijc.28636. Epub 2013 Dec 30.

39.

Phylogenetically related, clinically different: human papillomaviruses 6 and 11 variants distribution in genital warts and in laryngeal papillomatosis.

Godínez JM, Nicolás-Párraga S, Pimenoff VN, Mengual-Chuliá B, Muñoz N, Bosch FX, Sánchez GI, McCloskey J, Bravo IG.

Clin Microbiol Infect. 2014 Jun;20(6):O406-13. doi: 10.1111/1469-0691.12420. Epub 2013 Dec 9.

40.

The occasional role of low-risk human papillomaviruses 6, 11, 42, 44, and 70 in anogenital carcinoma defined by laser capture microdissection/PCR methodology: results from a global study.

Guimerà N, Lloveras B, Lindeman J, Alemany L, van de Sandt M, Alejo M, Hernandez-Suarez G, Bravo IG, Molijn A, Jenkins D, Cubilla A, Muñoz N, de Sanjose S, Bosch FX, Quint W; RIS HPV TTHPV VVAPO study groups.

Am J Surg Pathol. 2013 Sep;37(9):1299-310. doi: 10.1097/PAS.0b013e31828b6be4.

PMID:
24076770
41.

Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva.

de Sanjosé S, Alemany L, Ordi J, Tous S, Alejo M, Bigby SM, Joura EA, Maldonado P, Laco J, Bravo IG, Vidal A, Guimerà N, Cross P, Wain GV, Petry KU, Mariani L, Bergeron C, Mandys V, Sica AR, Félix A, Usubutun A, Seoud M, Hernández-Suárez G, Nowakowski AM, Wilson G, Dalstein V, Hampl M, Kasamatsu ES, Lombardi LE, Tinoco L, Alvarado-Cabrero I, Perrotta M, Bhatla N, Agorastos T, Lynch CF, Goodman MT, Shin HR, Viarheichyk H, Jach R, Cruz MO, Velasco J, Molina C, Bornstein J, Ferrera A, Domingo EJ, Chou CY, Banjo AF, Castellsagué X, Pawlita M, Lloveras B, Quint WG, Muñoz N, Bosch FX; HPV VVAP study group.

Eur J Cancer. 2013 Nov;49(16):3450-61. doi: 10.1016/j.ejca.2013.06.033. Epub 2013 Jul 22.

PMID:
23886586
42.

Methylation of human papillomavirus Type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR.

Jacquin E, Baraquin A, Ramanah R, Carcopino X, Morel A, Valmary-Degano S, Bravo IG, de Sanjosé S, Riethmuller D, Mougin C, Prétet JL.

J Clin Microbiol. 2013 Oct;51(10):3207-15. doi: 10.1128/JCM.01106-13. Epub 2013 Jul 17.

43.

Multiple evolutionary origins of bat papillomaviruses.

García-Pérez R, Gottschling M, Wibbelt G, Bravo IG.

Vet Microbiol. 2013 Jul 26;165(1-2):51-60. doi: 10.1016/j.vetmic.2013.01.009. Epub 2013 Feb 5.

PMID:
23481575
44.

The biology and life-cycle of human papillomaviruses.

Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, Stanley MA.

Vaccine. 2012 Nov 20;30 Suppl 5:F55-70. doi: 10.1016/j.vaccine.2012.06.083. Review.

PMID:
23199966
45.

Differential presence of Papillomavirus variants in cervical cancer: an analysis for HPV33, HPV45 and HPV58.

Godínez JM, Heideman DA, Gheit T, Alemany L, Snijders PJ, Tommasino M, Meijer CJ, de Sanjosé S, Bosch FX, Bravo IG.

Infect Genet Evol. 2013 Jan;13:96-104. doi: 10.1016/j.meegid.2012.09.011. Epub 2012 Sep 26.

PMID:
23022714
46.

Novel animal papillomavirus sequences and accurate phylogenetic placement.

Mengual-Chuliá B, García-Pérez R, Gottschling M, Nindl I, Bravo IG.

Mol Phylogenet Evol. 2012 Dec;65(3):883-91. doi: 10.1016/j.ympev.2012.08.011. Epub 2012 Aug 29.

PMID:
22960206
47.

An ancient history of gene duplications, fusions and losses in the evolution of APOBEC3 mutators in mammals.

Münk C, Willemsen A, Bravo IG.

BMC Evol Biol. 2012 May 28;12:71. doi: 10.1186/1471-2148-12-71.

48.

The evolution of Dscam genes across the arthropods.

Armitage SA, Freiburg RY, Kurtz J, Bravo IG.

BMC Evol Biol. 2012 Apr 13;12:53. doi: 10.1186/1471-2148-12-53.

49.

EcPV2 DNA in equine genital squamous cell carcinomas and normal genital mucosa.

Bogaert L, Willemsen A, Vanderstraeten E, Bracho MA, De Baere C, Bravo IG, Martens A.

Vet Microbiol. 2012 Jul 6;158(1-2):33-41. doi: 10.1016/j.vetmic.2012.02.005. Epub 2012 Feb 11.

PMID:
22397936
50.

Performance of the digene LQ, RH and PS HPVs genotyping systems on clinical samples and comparison with HC2 and PCR-based Linear Array.

Godínez JM, Tous S, Baixeras N, Moreno-Crespi J, Alejo M, Lejeune M, Bravo IG, Bosch FX, de Sanjosé S.

Infect Agent Cancer. 2011 Nov 18;6:23. doi: 10.1186/1750-9378-6-23.

Supplemental Content

Loading ...
Support Center